EssilorLuxottica
ISIN: FR0000121667 | Ticker: EL | LEI: 549300M3VH1A3ER1TB49
Country: France
EssilorLuxottica, a fully integrated player, is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company brings together the complementary expertise of two industry pioneers, one in advanced lens technologies and the other in the craftsmanship of iconic eyewear, to create a vertically-integrated business that is uniquely positioned to address the world’s evolving vision needs and the global demand of a growing eyewear industry. Founded in 1849, Essilor’s long history is bound to its mission of improving lives by improving sight. This mission has borne major technological advances such as the invention of the organic lens and the progressive lens.
Year founded2018
Served areaWorldwide
Headcount180,000
Headquarters147 Rue de Paris, 94220 Charenton-Le-Pont – France
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 52,318,000,000.00 | 59,415,000,000.00 | 60,561,000,000.00 |
| Noncurrent Assets | N/A | 38,598,000,000.00 | 50,140,000,000.00 | 51,920,000,000.00 |
| Property Plant And Equipment | N/A | 3,348,000,000.00 | 4,211,000,000.00 | 4,747,000,000.00 |
| Goodwill | N/A | 22,658,000,000.00 | 29,104,000,000.00 | 30,734,000,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 10,031,000,000.00 | 12,599,000,000.00 | 12,122,000,000.00 |
| Investment Accounted For Using Equity Method | N/A | 17,000,000.00 | 91,000,000.00 | 83,000,000.00 |
| Deferred Tax Assets | N/A | 418,000,000.00 | 487,000,000.00 | 408,000,000.00 |
| Other Noncurrent Assets | N/A | 374,000,000.00 | 718,000,000.00 | 817,000,000.00 |
| Inventories | N/A | 1,930,000,000.00 | 2,445,000,000.00 | 2,789,000,000.00 |
| Current Trade Receivables | N/A | 2,066,000,000.00 | 2,355,000,000.00 | 2,697,000,000.00 |
| Current Tax Assets Current | N/A | 195,000,000.00 | 296,000,000.00 | 259,000,000.00 |
| Cash and cash equivalents | 4,836,000,000.00 | 8,683,000,000.00 | 3,293,000,000.00 | 1,960,000,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 13,720,000,000.00 | 9,193,000,000.00 | 8,641,000,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | 82,000,000.00 | 0.00 |
| Other Current Assets | N/A | 847,000,000.00 | 804,000,000.00 | 936,000,000.00 |
| Equity And Liabilities | N/A | 52,318,000,000.00 | 59,415,000,000.00 | 60,561,000,000.00 |
| Equity | 35,332,000,000.00 | 32,798,000,000.00 | 35,875,000,000.00 | 38,147,000,000.00 |
| Issued Capital | N/A | 79,000,000.00 | 80,000,000.00 | 81,000,000.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | N/A | 1,448,000,000.00 | 2,152,000,000.00 |
| Share Premium | N/A | 22,012,000,000.00 | 22,381,000,000.00 | 23,066,000,000.00 |
| Treasury Shares | N/A | 201,000,000.00 | 231,000,000.00 | 360,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 32,268,000,000.00 | 35,064,000,000.00 | 37,455,000,000.00 |
| Noncontrolling Interests | N/A | 530,000,000.00 | 811,000,000.00 | 692,000,000.00 |
| Noncurrent Liabilities | N/A | 13,349,000,000.00 | 14,602,000,000.00 | 13,525,000,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 484,000,000.00 | 537,000,000.00 | 431,000,000.00 |
| Other Longterm Provisions | N/A | 170,000,000.00 | 243,000,000.00 | 302,000,000.00 |
| Deferred Tax Liabilities | N/A | 1,887,000,000.00 | 2,536,000,000.00 | 2,377,000,000.00 |
| Other Noncurrent Liabilities | N/A | 73,000,000.00 | 143,000,000.00 | 221,000,000.00 |
| Longterm Borrowings | N/A | 9,324,000,000.00 | 8,913,000,000.00 | 7,858,000,000.00 |
| Other Shortterm Provisions | N/A | 271,000,000.00 | 373,000,000.00 | 283,000,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 1,864,000,000.00 | 2,218,000,000.00 | 2,297,000,000.00 |
| Current Tax Liabilities Current | N/A | 530,000,000.00 | 805,000,000.00 | 711,000,000.00 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 6,171,000,000.00 | 8,925,000,000.00 | 8,888,000,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | 13,000,000.00 | 0.00 |
| Other Current Liabilities | N/A | 2,346,000,000.00 | 3,655,000,000.00 | 3,587,000,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 633,000,000.00 | 1,036,000,000.00 | 1,164,000,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 14,429,000,000.00 | 19,820,000,000.00 | 24,494,000,000.00 |
| Profit Loss From Operating Activities | 452,000,000.00 | 2,307,000,000.00 | 3,157,000,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 1,000,000.00 | 3,000,000.00 | 6,000,000.00 |
| Profit Loss Before Tax | 313,000,000.00 | 2,181,000,000.00 | 3,032,000,000.00 |
| Income Tax Expense Continuing Operations | 164,000,000.00 | 582,000,000.00 | 751,000,000.00 |
| Profit Loss From Continuing Operations | 149,000,000.00 | 1,598,000,000.00 | 2,281,000,000.00 |
| Profit (loss) | 149,000,000.00 | 1,598,000,000.00 | 2,281,000,000.00 |
| Profit Loss Attributable To Owners Of Parent | 85,000,000.00 | 1,448,000,000.00 | 2,152,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 64,000,000.00 | 150,000,000.00 | 128,000,000.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 149,000,000.00 | 1,598,000,000.00 | 2,281,000,000.00 |
| Adjustments For Income Tax Expense | N/A | 164,000,000.00 | 582,000,000.00 | 751,000,000.00 |
| Adjustments For Provisions | N/A | 63,000,000.00 | 38,000,000.00 | -51,000,000.00 |
| Adjustments For Sharebased Payments | N/A | 156,000,000.00 | 160,000,000.00 | 191,000,000.00 |
| Other Adjustments For Noncash Items | N/A | -22,000,000.00 | -31,000,000.00 | -72,000,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | 6,000,000.00 | 2,000,000.00 | 2,000,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 112,000,000.00 | 125,000,000.00 | 125,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 356,000,000.00 | 618,000,000.00 | 940,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 2,953,000,000.00 | 4,545,000,000.00 | 4,783,000,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 133,000,000.00 | 7,078,000,000.00 | 965,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -480,000,000.00 | -8,060,000,000.00 | -2,619,000,000.00 |
| Payments From Changes In Ownership Interests In Subsidiaries | N/A | 94,000,000.00 | 67,000,000.00 | 674,000,000.00 |
| Proceeds From Issuing Shares | N/A | 36,000,000.00 | 34,000,000.00 | 37,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 159,000,000.00 | 317,000,000.00 | 431,000,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 461,000,000.00 | 722,000,000.00 | 955,000,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | -244,000,000.00 | 18,000,000.00 | -507,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 1,498,000,000.00 | -2,040,000,000.00 | -3,580,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 3,970,000,000.00 | -5,555,000,000.00 | -1,417,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -123,000,000.00 | 166,000,000.00 | 83,000,000.00 |
| Cash and cash equivalents | 4,836,000,000.00 | 8,683,000,000.00 | 3,293,000,000.00 | 1,960,000,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 21.08.23 | None | Other | Sell | EUR 2,534,525.00 |
| 27.07.23 | None | Other | Buy | EUR 124,032.02 |
| 14.06.23 | None | Other | Sell | EUR 167,330.20 |
| 14.06.23 | None | Other | Other | EUR 0.00 |
| 13.06.23 | None | Other | Other | EUR 1,429,685.35 |
| 13.06.23 | None | Other | Other | EUR 1,077,453.36 |
| 13.06.23 | None | Other | Other | EUR 70,639.49 |
| 13.06.23 | None | Other | Other | EUR 46,502.99 |
| 13.06.23 | None | Other | Other | EUR 19,148.29 |
| 13.06.23 | None | Other | Other | EUR 16,091.00 |
FR0000121667
LEI549300M3VH1A3ER1TB49
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryCAC40
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.